189 related articles for article (PubMed ID: 27709778)
1. Liver fibrosis with hypereosinophilia causing transient abnormal myelopoiesis.
Minakata S; Sakata N; Wada N; Konishi Y; Marutani S; Enya T; Nakagawa H; Wada H; Takemura T
Pediatr Int; 2016 Nov; 58(11):1222-1225. PubMed ID: 27709778
[TBL] [Abstract][Full Text] [Related]
2. Transient abnormal myelopoiesis in non-Down syndrome neonate.
Ohkawa T; Miyamoto S; Sugie M; Tomizawa D; Imai K; Nagasawa M; Morio T; Mizutani S; Takagi M
Pediatr Int; 2015; 57(1):e14-7. PubMed ID: 25711269
[TBL] [Abstract][Full Text] [Related]
3. Transient abnormal myelopoiesis of a newborn not associated with chromosome 21 abnormalities or GATA1 mutations.
Nakashima MO; Shetty S; Chicka M; Flagg A; Eng C; Cotta CV
Pediatr Blood Cancer; 2015 Feb; 62(2):353-355. PubMed ID: 25175265
[TBL] [Abstract][Full Text] [Related]
4. Placental Pathology in Down Syndrome-Associated Transient Abnormal Myelopoiesis.
Kuo E; Kumarapeli AR
Arch Pathol Lab Med; 2020 Mar; 144(3):388-393. PubMed ID: 30969155
[TBL] [Abstract][Full Text] [Related]
5. Prominent megakaryocytic dysplasia after regression of transient abnormal myelopoiesis associated with GATA-1 mutation.
Anoop P; Atra A
J Pediatr Hematol Oncol; 2012 Nov; 34(8):640. PubMed ID: 23007419
[TBL] [Abstract][Full Text] [Related]
6. [Abnormal hematopoiesis in Down syndrome].
Ito E
Rinsho Ketsueki; 2014 Oct; 55(10):1738-47. PubMed ID: 25297735
[No Abstract] [Full Text] [Related]
7. Down syndrome-related transient abnormal myelopoiesis is attributed to a specific erythro-megakaryocytic subpopulation with
Nishinaka-Arai Y; Niwa A; Matsuo S; Kazuki Y; Yakura Y; Hiroma T; Toki T; Sakuma T; Yamamoto T; Ito E; Oshimura M; Nakahata T; Saito MK
Haematologica; 2021 Feb; 106(2):635-640. PubMed ID: 32354872
[No Abstract] [Full Text] [Related]
8. Resolution of liver disease in transient abnormal myelopoiesis with fish oil emulsion.
Watanabe T; Amari S; Tsukamoto K; Ito Y; Tomizawa D; Yoshioka T; Kanamori Y
Pediatr Int; 2017 Apr; 59(4):515-518. PubMed ID: 28401746
[TBL] [Abstract][Full Text] [Related]
9. Transient leukemia in a newborn without Down syndrome: case report and review of the literature.
Rozen L; Huybrechts S; Dedeken L; Heijmans C; Dessars B; Heimann P; Lambert F; Noubouossie DF; Ferster A; Demulder A
Eur J Pediatr; 2014 Dec; 173(12):1643-7. PubMed ID: 24253371
[TBL] [Abstract][Full Text] [Related]
10. Recent advances in the understanding of transient abnormal myelopoiesis in Down syndrome.
Watanabe K
Pediatr Int; 2019 Mar; 61(3):222-229. PubMed ID: 30593694
[TBL] [Abstract][Full Text] [Related]
11. Successful Liver Transplantation for Transient Abnormal Myelopoiesis-Associated Liver Failure.
Yasuoka K; Inoue H; Tanaka K; Fujiyoshi J; Matsushita Y; Ochiai M; Koga Y; Matsuura T; Taguchi T; Ohga S
Neonatology; 2017; 112(2):159-162. PubMed ID: 28558383
[TBL] [Abstract][Full Text] [Related]
12. Transient abnormal myelopoiesis (TAM) in a neonate without Down syndrome.
Bidet A; Dulucq S; Aladjidi N
Br J Haematol; 2015 Jan; 168(1):2. PubMed ID: 25308890
[No Abstract] [Full Text] [Related]
13. Distinct GATA1 Point Mutations in Monozygotic Twins With Down Syndrome and Transient Abnormal Myelopoiesis From a Triplet Pregnancy: A Case Report and Review of Literature.
Yin L; Lovell MA; Wilson ML; Wei Q; Liang X
Am J Clin Pathol; 2016 Dec; 146(6):753-759. PubMed ID: 28028114
[TBL] [Abstract][Full Text] [Related]
14. Comment on: Clinical, cytogenetic, and molecular analyses of 17 neonates with transient abnormal myelopoiesis and nonconstitutional trisomy 21.
Aksu T; Gümrük F; Ünal Ş
Pediatr Blood Cancer; 2020 Nov; 67(11):e28289. PubMed ID: 32725847
[No Abstract] [Full Text] [Related]
15. Transient abnormal myelopoiesis in a phenotypically normal newborn with polyclonal trisomy 21.
Corazza F; Astolfi A; Libri V; Franzoni M; Serravalle S; Alessandroni R; Melchionda F; Pession A
Int J Hematol; 2014 Jun; 99(6):794-7. PubMed ID: 24771229
[TBL] [Abstract][Full Text] [Related]
16. A Case of Novel GATA-1 Mutation-positive Transient Abnormal Myelopoiesis With Life-threatening Complications in a Neonate With Down Syndrome.
Sah RR; Ray S; Bhatia P; Dhir SK; Totadri S; Kumar N; Kumar P
J Pediatr Hematol Oncol; 2021 Mar; 43(2):e292-e295. PubMed ID: 31876781
[TBL] [Abstract][Full Text] [Related]
17. Spontaneous resolution of transient abnormal myelopoiesis between 34 and 40 weeks gestation.
Maracaja DLV; Rinder H
Br J Haematol; 2020 Feb; 188(4):481. PubMed ID: 31815289
[No Abstract] [Full Text] [Related]
18. Prenatal diagnosis of transient abnormal myelopoiesis in three fetuses with Down syndrome: heterogeneous ultrasonographic findings and outcomes.
Rizzo A; Perotti G; Fiandrino G; Spinillo A; Stronati M; Iasci A
Ultrasound Obstet Gynecol; 2018 Mar; 51(3):412-413. PubMed ID: 28600809
[No Abstract] [Full Text] [Related]
19. Two patients of trisomy 21 with transient abnormal myelopoiesis with hypereosinophilia without blasts in peripheral blood smears.
Okamoto T; Nagaya K; Sugiyama T; Aoyama A; Nii M; Azuma H
Pediatr Hematol Oncol; 2021 Mar; 38(2):168-173. PubMed ID: 33150826
[TBL] [Abstract][Full Text] [Related]
20. The hematopoietic microenvironment of the fetal liver and transient abnormal myelopoiesis associated with Down syndrome: A review.
Miyauchi J
Crit Rev Oncol Hematol; 2024 Jul; 199():104382. PubMed ID: 38723838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
